Status:
TERMINATED
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Crohn's and Colitis Foundation
Conditions:
Crohn's Disease
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Hypothesis:In patients with ulcerative colitis and Crohn's disease diagnosed with mild or moderate anaemia: 1. iron supplementation will increase disease activity and oxidative stress 2. the addition...
Detailed Description
To maintain site/extent of disease and medication consistent among groups, the design is a double blind crossover placebo-controlled trial. 1. If mild anaemia, patients are randomized to 300 mg of fe...
Eligibility Criteria
Inclusion
- \> 18 years old
- diagnosed with inflammatory Bowel Disease (ulcerative colitis and Crohn's disease)
- with mild or moderate anaemia
Exclusion
- not diagnosed with bowel obstruction
- not diagnosed with short bowel syndrome
- not taking iron supplement or antioxidant vitamins and minerals
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00152841
Start Date
June 1 2002
Last Update
March 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network - Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4